Long-term treatment with pacritinib on a compassionate use basis in patients with advanced myelofibrosis

Haematologica. 2023 Jul 1;108(7):1960-1964. doi: 10.3324/haematol.2022.282089.
No abstract available

Publication types

  • Letter

MeSH terms

  • Bridged-Ring Compounds
  • Compassionate Use Trials
  • Humans
  • Janus Kinase 2
  • Primary Myelofibrosis* / drug therapy
  • Pyrimidines / therapeutic use

Substances

  • 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
  • Bridged-Ring Compounds
  • Pyrimidines
  • Janus Kinase 2